|
Click to listen/view OPRX 2Q 2013 Investor Call
stock symbol: OPRX About OPTIMIZERx CorporationOPTIMIZERx Corporation provides unique consumer & physician platforms and strategies to help patients better afford and comply with their medicines and healthcare products, while offering pharmaceutical and healthcare companies more effective ways to expand physician and patient awareness, access and adherence to their medications and available product support. The Company's core product offering is our SampleMD™ software application which delivers an automated system that replaces traditional physical drug samples by enabling doctors or other healthcare providers to automatically print and electronically distribute sample vouchers or co-pay discount coupons within their ePrescribing/ EHR (electronic health record) system or from their computer desktops. Through SampleMD, pharmaceutical and biotech manufacturers now have a digital paperless platform to directly offer patient's critical cost savings, patient education and adherence tools right at point of prescribing. The Company's consumer support website, www.OPTIMIZERx.com, and its permanent subscriber base exceeding 2.5 million patients, continues to grow each month and is quickly becoming the preferred way to access branded prescription vouchers, co-pay savings and other support programs. Additionally, the company recently announced the launch of OPTIMZEHR™, the company's consulting and implementation practice to assist both pharmaceutical-biotech companies and healthcare provider platforms in determining and executing on mutually beneficial opportunities to jointly assist physicians and patients within their electronic health record (EHR) workflow. For more information on the company, please contact us at 248-651-6568. For investor relations, please contact Chris Schreiber at Taglich Brothers, Inc. at 917-445-6207. |
|
